MODERN VIEW ON THE PROBLEMS OF ACCOMPANYING THERAPY IN GYNECOLOGICAL ONCOLOGICAL PATHOLOGY. Epidemiology of gynecological oncology pathology (Review article)

1. FIGO Committee on Gynecologic Oncology. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynecol Obstet 2019;145(1):129–35.
2.  Amit A., Schink J., Reiss A. et al. PET/CT in gynecologic cancer: present applications and future prospects – a clinician’s perspective. Obstet Gynecol Clin North Am 2011;38(1):1–21
3. Shepherd J.H., Spencer C., Herod J., Ind T.E. Radical vaginal trachelectomy as a fertilitysparing procedure in women with early-stage cervical cancercumulative pregnancy rate in a series of 123 women. BJOG 2006;113(6):719–24.
4. Ramirez P., Frumovitz M., Pareja R. et.al. Phase III randomized trial of laparoscopic or robotic radical hysterectomy vs. abdominal radical hysterectomy in patients with early-stage cervical cancer: LACC Trial. N Engl J Med 2018;379(20):1895–904. DOI: 10.1056/NEJMoa1806395.
5. Elliott P., Coppleson M., Russell P. et al. Early invasive (FIGO stage IA) carcinoma of the cervix: a clinico-pathologic study of 476 cases. Int J Gynecol Cancer 2000;10(1):42–52.
6. Whitney C.W., Sause W., Bundy B.N. et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 199;17(50:1339–48.
7. 7. Radzinsky V.E., Ordiyants I.M., Abdurakhmanova M.B. Combination of probiotic and metabiotic in complex therapy of dysbiosis // Obstetrics and gynecology: News. Opinions. Training.– 2018. – T. 6. – № 3. – С. 127–133.
8. Zhang Q. et al. Oncologic and obstetrical outcomes with fertility-sparing treatment of cervical cancer: a systematic review and meta-analysis //Oncotarget. – 2017. – Т. 8. – №. 28. – С. 46580.
9. Huang H., Liu J., Li Y. et al. Metastasis to deep obturator and para-aortic lymph nodes in 649 patients with cervical carcinoma. Eur J Surg Oncol
10. Sedlis A., Bundy B.N., Rotman M.Z. et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study. Gynecol Oncol
11. Morris M., Eifel P.J., Lu J. et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999;340(15):1137–43.

Rydzewska L., Tierney J., Vale C.L. et al. Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer. Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD007406.

12. Lanciano R.M., Pajak TF., Martz K., Hanks G.E. The influence of treatment time onoutcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care study. Int J Radiat Oncol Biol Phys 1993;25(3):
13. Lorusso D., Petrelli F., Coinu A. et al. A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer. Gynecol Oncol 2014;133:117–23.
14. Pötter R., Haie-Meder C., van Limbergen E. et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy – 3D dose volume parameters and aspects of 3D imagebased anatomy, radiation physics, radiobiology. Radiother Oncol 2006;78:67–77.
15. Кветной И., Кветная Т., Бочарова К. Мелатонин и патология пожилого возраста //Врач. – 2014. – №. 6. – С. 53-56.
16. 17. Maltseva A.N. The use of liposomal gel coating "Flamena" in the treatment of dystrophic diseases of the vulva in women of the perimenopausal period // Modern problems of science and education.– 2018.
17. Rogovskaya S.I. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western Countries of the former Soviet Union, Caucasus Region and Central Asia. Vaccine 2013;31:H46–58.
18. FIGO Committee on Gynecologic Oncology. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynecol Obstet
19. 29. FIGO Committee on Gynecologic Oncology. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynecol Obstet 2019;145(1):129–35.
20. Радзинский В.Е., Ордиянц И.М., Абдурахманова М.Б. Комбинация пробиотика и метабиотика в комплексной терапии дисбиозов // Акушерство и гинекология: Новости. Мнения. Обучения. – 2018. – T. 6.
21. . Orazov M.R., Radzinsky V.E., Khamoshina M.B., Nosenko E.N., Dukhin A.O., Tokaeva E.S., Barseghyan L.K., Shkreli I., Marapov D.I. ., Simenel
22. 23. D.A., Nizhnik A.N. Vitamin D3 (cholecalciferol) and pelvic pain induced by ovarian endometriosis // Difficult patient. – 2018. – T.16. – №4.

24. Kjaer S.K., Frederiksen K., Munk C., Iftner T. Long-term abcolut risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst 2010;102(19):1478–88.

25. Kaprin A.D., Starinsky V.V., Petrova G.V. Malignant neoplasms in Russia in 2018 (morbidity and mortality). M.: MNIOI im. P.A. Herzen - branch of the Federal State Budgetary Institution "National Medical Research Center of Radiology" of the Ministry of Health of Russia, 2019. 250 p.

26. Bermudez A., Bhatla N., Leung E. FIGO cancer report 2015. Cancer of the cervix uteri. IntJ Gynecol Obstet 2015;131:S88–95.

27. Usmanova E.B., Obukhova O.A., Shchelkova O.Yu. Quality of life and sexual health of patients with ovarian malignancies. Oncogynecology.2020. № 2 (34). С. 77–80. doi: 10.52313/22278710_2020_2_77.

28. Thornquist C. The potential of dance: Reducing fashion consumption through movement therapy //Journal of Cleaner Production. – 2018. – Т. 183. – С. 824-

29. Rodríguez A.C., Schiffman M., Herrero R. et al. Longitudinal study of human

papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J Natl Cancer Inst 2010;102(5):315–24.

30. Webb J.C., Key C.R., Qualls C.R. et al. Population-based study of microinvasive adenocarcinoma of the uterine cervix. Obstet Gynecol 2001;97(5 Pt

31. Solopova A.G., Idrisova L.E., Vlasina A.Yu., Moskvicheva V.S. Possibilities of restoring sexual function in women of reproductive age after treatment of endometrial cancer and borderline ovarian tumors // Doctor. – 2018; 29 (10): 16–

32. Kim H.S., Sardi J.E., Katsumata N. et al. Efficacy of neoadjuvant chemotherapy in patients with FIGO stage IB1 to IIA cervical cancer: an international collaborative meta-analysis. Eur J SurgOncol 2013;39:115–24.

33. Gupta S., Maheshwari A., Parab P. et al. Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage IB2, IIA, or IIB squamous cervical cancer: a randomized controlled trial. J Clin Oncol 2018;36(16):1548–55.

34. Tian Zhong-ze, Li Sha, Wang Yue et al. Investigation of uterine arterial chemoembolization and uterine infusion chemotherapy for advanced cervical cancer before radical radiotherapy: a long-term follow-up study. Arch Gynecol

35. Morley G.W., Hopkins M.P., Lindenauer S.M. et al. Pelvic exenteration, University of Michigan: 100 patients at 5 years. Obstet Gynecol 1989;74(6):934–

36. Mabuchi S et al. Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients./ J Gynecol Oncol. 2017 Jan;28(1):e15. doi: 10.3802/jgo.2017.28.e15

37. Wang S et al. Efficacy of concurrent chemoradiotherapy plus adjuvant chemotherapy on advanced cervical cancer./ Chin J Cancer. 2010 Nov;29(11):59-

38. Sapienza L. G. et al. Decrease in uterine perforations with ultrasound image-guided applicator insertion in intracavitary brachytherapy for cervical cancer: A systematic review and meta-analysis //Gynecologic oncology. – 2018. – Т. 151. –